论文部分内容阅读
目的对凝血功能测定在晚期恶性肿瘤患者的临床意义进行分析和探讨。方法 176例恶性肿瘤患者作为观察组,同时选取同期80例健康体检者作为对照组,对两组患者的D-二聚体水平以及凝血功能等进行检查。结果与健康对照组相比,观察组患者的TT以及PT延长明显,差异有统计学意义(P<0.05),而D-二聚体水平以及Fib水平显著升高,两组差异具有统计学意义(P<0.05)。相对于健康对照组而言,观察组患者的APTT水平差异无统计学意义(P>0.05)。结论在对恶性肿瘤患者的高凝状态进行观测的时候,检测恶性肿瘤患者的D-二聚体水平以及Fib具有一定的意义。
Objective To analyze and discuss the clinical significance of coagulation test in patients with advanced malignant tumors. Methods Totally 176 patients with malignant tumor were selected as the observation group and 80 healthy subjects at the same time were selected as the control group. The D-dimer level and coagulation function of the two groups were examined. Results Compared with the healthy control group, TT and PT prolonged significantly in the observation group (P <0.05), while the levels of D-dimer and Fib in the observation group increased significantly, with significant difference between the two groups (P <0.05). There was no significant difference in the level of APTT between the observation group and the healthy control group (P> 0.05). Conclusions When observing hypercoagulable state in patients with malignant tumors, detecting D-dimer levels and Fib in patients with malignant tumors is of some significance.